v1
Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1,000-mg daily dosages. Topiramate YE Study Group.
- NobleID
- NI4P67W92R98S18
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/C3F911CE
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims